Case study of WHOAbortion care guideline(2022) Contents Acknowledgements.................................................................................................................................................. iiiBackground................................................................................................................................................................ 1Meaningful youth engagement in a WHO guideline development process.................................................... 2Phases of the WHO guideline development process: an overview...........................................................................2Incorporating youth engagement in the WHO guideline development process: an illustrative example........3Key considerations for meaningful youth engagement in guideline development processes..................... 4Phase 1: Planning....................................................................................................................................................................5Youth engagement.........................................................................................................................................................................................5Example activities...........................................................................................................................................................................................5Phase 2: Development..........................................................................................................................................................5Purpose...............................................................................................................................................................................................................5Youth engagement.........................................................................................................................................................................................5Activities..............................................................................................................................................................................................................5Phase 3: Publishing and updating......................................................................................................................................6Purpose...............................................................................................................................................................................................................6Youth engagement.........................................................................................................................................................................................6Activities..............................................................................................................................................................................................................6Key considerations.................................................................................................................................................... 7Conclusions................................................................................................................................................................ 7References.................................................................................................................................................................. 8 Acknowledgements The UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training inHuman Reproduction (HRP) and the World Health Organization (WHO), Department of Sexual, Reproductive, Maternal, Child,Adolescent Health and Ageing (LHR) gratefully acknowledges the contributions of many individuals and organizations to thedevelopment of theAbortion care guidelineand this technical brief. This technical brief was written byMichalina Drejza(Consultant, Prevention of Unsafe Abortion Unit, WHO LHRDepartment) andCaron Kim(Medical Officer, Prevention of Unsafe Abortion Unit, WHO LHR Department). We express our sincere gratitude to the WHO Prevention of Unsafe Abortion Unit, in particularBela Ganatra(Head of Unit),Antonella Lavelanet,Ferid Abubeker, Kidist Gizachew, Polyphile NtihinyurwaandJessica Morris, for their valuablecontributions and guidance. We would like to thank members of our Youth for Abortion Taskforce:Gisèle Agbossaga(Benin),Stephen Chikwa(Zambia),Christelle Favre(Switzerland),Abdul Hanan Saani Inusah(Ghana),David Karorero(Burundi/Denmark),Jennifer Kayombo(United Republic of Tanzania),Ankita Khanna(India),Appolinaire Loua(Guinea),Karan Parikh(India),Sadia Rahman(Bangladesh),Ruben Alan Avila Reyna(Mexico),Victor Pacifique Rwandarwacu(Rwanda),PrushaShwan M. Salih(Iraq/Kurdistan),Sarmad Muhammad Soomar(Pakistan) andTheogene Uwiringiyimana(Rwanda). We